Home » Health » Drug Reportedly Reduces Risk of Severe Coronavirus by 79% | COVID-19 | News | The Nouvelliste

Drug Reportedly Reduces Risk of Severe Coronavirus by 79% | COVID-19 | News | The Nouvelliste

Che inhaled therapy uses beta interferons, a natural protein that is involved in the body’s response to viruses.

The study was conducted on a relatively small sample of patients – 101 – and has not been peer reviewed, but it could revolutionize the way COVID-19 is treated. According to Synairgen Managing Director Richard Marsden, this could be a “major step forward”.

The study conducted with the University of Southampton concludes that patients treated with this drug have a 79% less chance than those who received a placebo of developing severe forms of the disease, i.e. requiring d be placed on a respirator, or die from it. Patients treated with SNG001 are more than twice as likely to be cured compared to those who received placebo.

Three of the patients (6%) treated with the placebo died, while no deaths were to be observed among those who were treated with SNG001.

“The results confirm our belief that interferon beta […] has enormous potential as an inhalation therapy to restore the immune response of the lungs, speeding up recovery and countering the impact of the SARS-CoV-2 virus, ”said Tom Wilkinson, professor of respiratory medicine who led in a statement. the test.

Professor Stephen Holgate, co-founder of Synairgen, for his part stressed that this treatment “restores the ability of the lungs to neutralize the virus or any mutation of the virus or co-infection with another respiratory virus such as influenza, as could be produce in the event of a resurgence of COVID-19 in winter ”.

“These results seem very impressive” and although the study only involved a small number of patients, they could “be a game-changer”, commented Professor Naveed Sattar of the University of Glasgow.

Steve Goodacre, professor of emergency medicine at the University of Sheffield, believes that these results are “not interpretable” as they stand, explaining that he “needs the full details, and perhaps more importantly, the trial protocol ”.

Until then, only one drug, dexamethasone, has proven that it can save people with COVID-19. Another treatment, the antiviral remdesivir, reduces the length of hospital stay, but not mortality.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.